Satish Singh,
Head
Dr. Satish Singh is Head of Drug Product Process Development, in the Drug Product Services group at Lonza AG. Prior to joining Lonza recently, Satish was Research Fellow and Group Leader at Pfizer’s BioTherapeutics Pharmaceutical R&D unit. Satish has more than 25 years’ experience in the industry in product development activities, and is an internationally recognized expert in all aspects of (bio)pharmaceutical Drug Product (biologics, vaccines and small molecules) development. His experience includes ophthalmics and parenterals, encompassing small molecules and biologics, and has been involved in the submission of several BLAs and INDs. Satish has a strong technical background, complemented by a deep understanding of regulatory challenges and the evolving regulatory landscap. He is involved in various professional groups through the AAPS as well as USP. His research interests also include the investigation of impact of freezing processes on proteins, use of computational approaches to mitigate develop-ability issues, and aggregation and immunogenicity. He obtained his B.Tech. from the Indian Institute of Technology, New Delhi, and an M.S. and Ph.D. in Chemical Engineering from Kansas State University. He holds the position of Adjunct Professor at the Dept. of Physical Pharmaceutical Chemistry at Uppsala University, Sweden.
|
|
|
